MedPath

Tumour markers response to chemotherapy in patients with colorectal liver metastases

Conditions
PATIENTS WITH LIVER COLORECTAL METASTASES NOT CANDIDATED TO SURGERY
MedDRA version: 14.1Level: LLTClassification code 10024700Term: Liver metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Therapeutic area: Diseases [C] - Cancer [C04]
Registration Number
EUCTR2012-000834-21-IT
Lead Sponsor
ISTITUTI FISIOTERAPICI OSPITALIERI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

COLORECTAL LIVER METASTASES
UNRESECTABLE ACCORDING TO NORTLINGER CLASSIFCIATION (ANN.ONCOL.2009)
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 270
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30

Exclusion Criteria

EXTENSION OF DISEASE OUTSIDE THE LIVER

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: COMPLETE LIVER RESECTION AFTER CHEMOTHERAPY;Secondary Objective: TIME TO SURGERY<br>TIME TO PROGRESSION<br>TOLERABILITY<br>RESPONSE RATE <br>OVERALL SURVIVAL;Primary end point(s): COMPLETE RESECTION OF LIVER METASTASES;Timepoint(s) of evaluation of this end point: 4 MONTHS
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): TIME TO PROGRESSION;Timepoint(s) of evaluation of this end point: 24 MONTHS
© Copyright 2025. All Rights Reserved by MedPath